Global LAG-3 Antagonist Pipeline Insight Report 2021: Emerging Drugs Include Tebotelimab (MacroGenics) & LAG525 (Novartis) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “LAG-3 Antagonist – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This “LAG-3 Antagonist – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies a…